Elpipodect

N/A

Report date: 2025/12/25 15:59:12
NME

Base Information

Drug NameElpipodect
Drug Alias NameMK-8189
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 10A inhibitors
TargetsPhosphodiesterase 10A
Therapy Area/IndicationsBipolar I DisorderSchizophreniaAlzheimer Disease +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBipolar I DisorderSchizophreniaAlzheimer Disease +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A